Autoimmune thyroid diseases

PP Ovčariček, R Görges, L Giovanella - Seminars in nuclear medicine, 2024 - Elsevier
Autoimmune thyroid diseases (AITDs) include a wide spectrum of thyroid diseases affecting
more commonly women than men. The most frequent forms are Graves' Disease (GD) and …

Immune checkpoint inhibitors-related thyroid dysfunction: epidemiology, clinical presentation, possible pathogenesis, and management

L Zhan, H Feng, H Liu, L Guo, C Chen… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs) are a group of drugs employed in the treatment of
various types of malignant tumors and improve the therapeutic effect. ICIs blocks negative co …

Thyroiditis: evaluation and treatment

BM Quintero, C Yazbeck, LB Sweeney - American family physician, 2021 - aafp.org
Thyroiditis is a general term for inflammation of the thyroid gland. The most common forms of
thyroiditis encountered by family physicians include Hashimoto, postpartum, and subacute …

Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

P Caron, S Grunenwald, L Persani… - Reviews in Endocrine …, 2022 - Springer
Levothyroxine (LT4) is a safe, effective means of hormone replacement therapy for
hypothyroidism. Here, we review the pharmaceutical, pathophysiological and behavioural …

Icariin induces developmental toxicity via thyroid hormone disruption in zebrafish larvae

M Wu, N Zheng, X Zhan, J He, M Xiao, Z Zuo… - Food and Chemical …, 2023 - Elsevier
Icariin (ICA) is a natural flavonoid isolated from the traditional Chinese medicinal herb,
Epimedium brevicornu Maxim. Although previous studies have reported that ICA exhibits …

Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency

G Adouvi, F Nawa, M Ballarotto… - Journal of Medicinal …, 2023 - ACS Publications
The retinoid X receptors (RXRs) are ligand-activated transcription factors involved in, for
example, differentiation and apoptosis regulation. Currently used reference RXR agonists …

Atorvastatin protects against cyclophosphamide-induced thyroid injury in rats via modulation of JNK/ERK/p38 MAPK signaling pathway

WY Abdelzaher, SA Abdel-Gaber, MA Fawzy… - International …, 2023 - Elsevier
Background Cancer chemotherapy is associated with various tissue toxicities that limit its
use. Cyclophosphamide (CYC) is one of the most commonly used antineoplastic and …

Increased risk of thyroid dysfunction by PD-1 and CTLA-4 blockade in patients without thyroid autoantibodies at baseline

S Iwama, T Kobayashi, Y Yasuda, T Okuji… - The Journal of …, 2022 - academic.oup.com
Background Previous studies showed that although the risk of thyroid dysfunction [thyroid
immune-related adverse events (irAEs)] induced by anti-programmed cell death-1 …

Endocrine immune-related adverse effects of immune-checkpoint inhibitors

V Trevisani, L Iughetti, L Lucaccioni… - Expert Review of …, 2023 - Taylor & Francis
Introduction Immune-checkpoint inhibitor therapy modulates the response of the immune
system acting against cancer. Two pathways impacted by this kind of treatment are the …

Elevated TSH level, TgAb, and prior use of ramucirumab or TKIs as risk factors for thyroid dysfunction in PD-L1 blockade

T Kobayashi, S Iwama, A Yamagami… - The Journal of …, 2022 - academic.oup.com
Background Thyroid dysfunction is frequently caused by treatment with antiprogrammed cell
death-1 ligand 1 antibodies (PD-L1-Abs) and anticancer drugs, including ramucirumab …